SELLAS Life Sciences Group, Inc. SLS Income Statement

Sellas life sciences group, inc. (SLS)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-
Gross Profit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Operating expenses:
Cost of revenue (excluding amortization of certain acquired intangible assets)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-
Research and development employee stock-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	0	0
Total research and development expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	15	493	0	0	0
Research and development
7,290	7,285	8,690	8,611	8,822	8,767	6,104	5,452	5,687	6,067	1,232	3,788	8,136	11,395	20,091	22,207	23,229	23,611	24,572	25,857	26,729	27,674	0	0	0	-	0	0	0	-	0	0	0	-	5,788	6,685	0	0	0
General and administrative
9,623	9,923	10,165	9,121	11,392	12,772	15,869	17,750	16,682	15,089	4,453	4,079	3,355	4,593	12,231	12,278	11,047	10,609	4,122	4,769	12,483	16,226	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,614	10,372	7,630	4,333	3,851	5,253	5,405	0	0	0
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,585	7,800	8,151	7,983	8,635	6,098	6,311	0	0	0
Amortization of certain acquired intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,669	-1,146	-905	0	2,538	2,576	0	0	0
Selling, general and administrative non-employee stock-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Fair value of common stock warrants issued for general and administrative services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Fair value of common stock warrants issued for general and administrative expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
General and administrative non-employee stock-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-
Total selling, general and administrative expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	8,919	9,341	0	0	0
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	21,199	17,119	15,026	11,621	12,486	14,707	16,026	0	0	0
Severance costs related to Merger
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Total operating expenses and operating loss
19,746	20,041	28,405	27,282	29,764	31,089	23,856	25,085	24,252	23,039	0	0	0	-	0	-	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Operating loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-15,988	-32,322	-34,485	-34,276	-34,220	-32,331	-34,263	-40,963	-43,900	-45,198	-41,524	-33,727	-28,489	-27,018	0	0	-	0	-	-	-	-	-	-	-	-
Non-operating income (expense):
Change in fair value of warrant liability
-976	-1,136	-1,068	-3,358	-3,614	-5,300	-5,340	-3,099	-1,881	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration
-337	-586	483	349	-8	-3,032	-4,025	-3,863	-3,411	0	0	0	0	-	0	5,717	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of liability-classified warrants
-	-	0	0	-	727	727	727	685	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-	-	0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Litigation settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Litigation settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants potentially settleable in cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16,314	-14,796	3,863	-1,162	-2,401	-7,002	-7,916	-16,556	23,692	32,041	29,206	44,001	0	0	0	-	-	-	-	-	-	0	-	-	-
Goodwill and intangible assets impairment loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,644	-3,285	-5,443	0	-	0	0	-	-	-
Interest income (expense), net
128	118	117	-16	-156	-266	-394	-422	-428	-462	461	-814	-1,205	-1,166	-2,157	-938	-626	-760	-775	-914	-1,021	-1,110	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Income (loss) from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-33,325	-33,408	-28,743	0	-	0	0	-	-	-
Total non-operating income (expense), net
767	668	1,668	4,457	4,174	2,041	960	-1,913	-2,643	-462	0	0	0	-	0	-	0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-33	-36	-38	-22	-7	-3	2	0	0	0
Other Income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Change in fair value of the contingent purchase price liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	-	7,784	7,880	8,301	3,022	6,727	5,301	11,300	-2,370	-6,555	-6,219	-11,463	9,086	1,304	4,311	0	0	0
Loss before income taxes
-	-	0	0	-	-	0	0	-	-	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-41,786	-27,464	-20,069	-6,103	-13,178	0	0	0	-	-	-	-	-	-
Loss on warrant exchange
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Income (loss) from continuing operations from continuing operations before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-34,377	0	0	0	-	-	-	-	-	-
Income tax benefit
-	-	0	0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	1,052	-1,114	-2,273	-3,814	-1,052	0	0	0	-	-	-	-	-	-
Loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,722	-26,809	-26,106	-24,946	-18,732	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-18,898	-19,292	-25,196	-21,284	-24,212	-27,670	-23,132	-27,297	-27,148	-23,754	-14,617	-17,091	-5,789	-17,681	-37,712	-48,809	-69,858	-63,902	-52,179	-40,326	-44,607	-36,606	-77,151	-80,265	-69,921	-76,678	-31,928	-28,902	-19,501	-34,969	-29,633	-28,847	-32,405	-11,485	-17,205	-13,871	0	0	0
Deemed dividend arising from the issuance of common stock to Series A convertible preferred stockholders under most favored nation provision
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend arising from warrant modifications
8,055	8,416	8,168	1,391	439	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend arising from beneficial conversion feature of convertible preferred stock
-	-	0	0	-	4,436	4,436	4,436	1,968	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend arising from the issuance of common stock to Series A convertible preferred stockholders under most favored nation provision
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impact of anti-dilution protection on liability-classified warrants
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-27,196	-27,951	-33,855	-31,820	-36,264	-41,251	-37,388	-32,408	-29,791	-24,429	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Per share information:
Net loss
-18,898	-19,292	-25,196	-21,284	-24,212	-27,670	-23,132	-27,297	-27,148	-23,754	-14,617	-17,091	-5,789	-17,681	-37,712	-48,809	-69,858	-63,902	-52,179	-40,326	-44,607	-36,606	-77,151	-80,265	-69,921	-76,678	-31,928	-28,902	-19,501	-34,969	-29,633	-28,847	-32,405	-11,485	-17,205	-13,871	0	0	0
Reclassification of unrealized gain upon sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Reclassification of unrealized gain upon sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Unrealized gain on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,795	3,903	0	-	0	0	-	-	-	-	-	-	-
Tax effect of reclassification of unrealized gain upon sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Tax effect of reclassification of unrealized gain upon sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Tax effect of unrealized gain on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	705	1,533	0	-	0	0	-	-	-	-	-	-	-
Unrealized gain on marketable securities, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Total comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-78,304	-30,206	-25,389	-13,606	-33,343	0	0	0	-	-	-	-	-	-
Basic net income (loss) per share, continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.41	0.91	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-0.04	-	-	-
Basic net loss per share, discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.25	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.01	-	-	-	-0.06	-	-	-
Basic net income (loss) per share (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.66	0.59	-1.84	-	-0.11	-0.10	-0.08	-	-0.05	-	-	-	-	-	-	-	-	0.00	-	-	-	-0.10	-	-	-
Basic and diluted per share, continuing operations (usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.46	-4.84	-0.04	-0.08	-0.06	-	-0.03	-	-	-	-	-	-	-	-0.09	-	-0.49	-	-0.09	-	-	-	-
Basic and diluted loss per share, discontinued operations (usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.38	-3.10	-0.07	-0.02	-0.02	-	-0.02	-	-	-	-	-	-	-	0.00	-	-0.03	-	-0.04	-	-	-	-
Net loss per common share attributable to common stockholders, basic and diluted (in dollars per share)
-0.66	3.01	-2.68	-0.13	-11.12	-128.04	-26.75	-1.26	-1.67	-0.04	-2.27	-4.50	-3.63	-	-	-	-	-	-	-	-	-	-	-0.17	-0.02	-0.52	-0.11	-0.11	-0.11	-	-0.09	-	-	-	-	-	-0.19	-0.23	-0.12
Weighted-average common shares outstanding, basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,465	9,101	8,968	-	161,857	161,383	-	-	-	-	-	-	-	-	-	-	-	65,112	-	-	-	-	-	-	-
Basic and diluted net loss per share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.52	-	-0.13	-	-	-	-
Weighted-average common shares outstanding, basic and diluted (in shares)
6,374	-26,792	4,281	32,298	447	-12,025	352	6,767	5,952	4,816	1,962	1,313	1,268	-	-	-	-	-	-	-	136,054	-329,489	119,038	118,083	116,244	106,748	87,319	83,656	83,002	-	67,265	-	47,967	-41,884,028	41,970,481	38,568	20,316	18,372	18,371,808
Diluted net income (loss) per share, continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	-	-	-	-0.04	-	-	-
Diluted net loss per share, discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.01	-	-	-	-0.06	-	-	-
Diluted net income (loss) per share (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	-	-	-	-0.10	-	-	-
Weighted-average common shares outstanding, diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,273	-	-	-	161,383	-	-	-	-	-	-	-	-	-	-	-	67,177	-	-	-	-	-	-	-